Emil Kakkis, President & CEO, Director at Ultragenyx Pharmaceutical, holds 2.79M shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 44.27K shares in BioMarin Pharmaceutical (Ticker: BMRN). Most recently, Emil Kakkis Sold ― shares of Ultragenyx Pharmaceutical on Sep 05, 2024 for an estimated value of 1.12M.
What is the percentage of profitable transactions made by Emil Kakkis?
The percentage of profitable transactions made by Emil Kakkis is 71%.
What is the average return per transaction made by Emil Kakkis?
The average return per transaction made by Emil Kakkis is 60.30%.
What stocks does Emil Kakkis hold?
Emil Kakkis holds: RARE, BMRN stocks.
What was Emil Kakkis’s latest transaction?
Emil Kakkis latest transaction was an Informative Sell of $1.12M.
What was Emil Kakkis's most profitable transaction?
Emil Kakkis’s most profitable transaction was an Informative Buy of RARE stock on March 13, 2020. The return on the trade was 192.90%.
What is Emil Kakkis's role in Ultragenyx Pharmaceutical?
Emil Kakkis's role in Ultragenyx Pharmaceutical is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.